Red Lobster Drops New Flavors Into Fan-Favorite Seafood Boil Lineup, Plus New Entrées and Festive Cocktails

The beloved seafood restaurant is also adding two new entrees and a limited-time winter cocktail lineup just in time for the holidays Calling all seafood enthusiasts! Red Lobster is dropping some exciting updates to its menu, including three new crave-worthy seafood boil flavors: Lemon Pepper Butter, a bright zesty kick, OLD BAY® & Butter, a […]

Fossil Announces Grant of Sanction Order

(NASDAQ:FOSL), RICHARDSON, Texas, Nov. 10, 2025 (GLOBE NEWSWIRE) — Fossil Group, Inc. (NASDAQ: FOSL) (the “Company“) announced today that its subsidiary, Fossil (UK) Global Services Ltd (the “Plan Company“), has been granted an order from the High Court of Justice of England and Wales (the “Sanction Order“) sanctioning the restructuring plan under Part 26A of

ERS Genomics and Dyadic Applied BioSolutions Sign CRISPR/Cas9 License Agreement

— License enables Dyadic AppliedBioSolutions to expand genetic engineering capabilities ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for diverse commercial applications, today announced they have signed a non-exclusive agreement granting access to ERS' foundational CRISPR/Cas9 patent portfolio. https://mma.prnewswire.com/media/2818566/ERS_Genomics_Logo.jpg The

Fossil Announces Grant of Sanction Order

Fossil Announces Grant of Sanction Order GlobeNewswire November 10, 2025 RICHARDSON, Texas, Nov. 10, 2025 (GLOBE NEWSWIRE) — Fossil Group, Inc. (NASDAQ: FOSL) (the “Company“) announced today that its subsidiary, Fossil (UK) Global Services Ltd (the “Plan Company“), has been granted an order from the High Court of Justice of England and Wales (the “Sanction

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

(Milan:RACE),(NYSE:RACE), Maranello (Italy), November 10, 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company“) informs that the Company has purchased, under the Euro 360 million share buyback program announced on July 31, 2025, as the eighth tranche of the multi-year share buyback program of approximately Euro 2 billion expected to be executed by 2026

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM GlobeNewswire November 10, 2025 Maranello (Italy), November 10, 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company“) informs that the Company has purchased, under the Euro 360 million share buyback program announced on July 31, 2025, as the eighth tranche of the multi-year share buyback program

CEO Receives Google.org Funding to Train Hundreds of Justice-Impacted Oklahomans in Advanced Careers and AI

Funding will empower hundreds of Oklahomans returning from incarceration to build digital fluency, gain high-demand skills, and access upwardly mobile employment The Center for Employment Opportunities (CEO) is proud to announce a transformative funding from Google.org, Google's philanthropic arm, to expand advanced career training opportunities and digital fluency for justice-impacted individuals across Oklahoma. This support

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

(NASDAQ:JSPR), LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

NX Investors Have Opportunity to Lead Quanex Building Products Corporation Securities Fraud Lawsuit with the Schall Law Firm

(NYSE:NX), LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Quanex Building Products Corporation (“Quanex” or “the Company”) (NYSE: NX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire November 10, 2025 LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ:

Scroll to Top